A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
Part of paid clinical trials in Bonita, California.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT06962280
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Tirzepatide — DRUGAdministered SC
- Placebo — DRUGAdministered SC
Study Details
The main purpose of this study is to find out how well and how safely tirzepatide works long-term in adults who have type 1 diabetes and obesity or overweight. Participation in the study will last about 20 months.
Key Dates
- Start date
- May 12, 2025
- Status verified
- Feb 2026
- Primary completion
- Nov 30, 2026
- Completion
- Jul 31, 2027
Study Design
- Enrollment
- 465 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TirzepatideParticipants will receive tirzepatide subcutaneously (SC)
- Placebo Comparator: PlaceboParticipants will receive placebo SC
Primary Outcome Measure
Change from Baseline in Hemoglobin A1c (HbA1c) [ Time Frame: Baseline, Week 40 ]
Locations (18)
Find similar trials in Bonita, CA
By condition
By specialty
By research site
Related Studies
- Healthy Start: Exploring the Fuel-mediated Programming of Neonatal GrowthRecruiting · University of Colorado, Denver · Aurora, Colorado
- Investigating the Impact of Obesity on Pubertal Development in GirlsRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina
- Bariatric Embolization of Arteries for the Treatment of Nonalcoholic SteatohepatitisNot Yet Recruiting · Keith Pereira, MD: · St Louis, Missouri
- Inflammation, Diabetes, Ethnicity and Obesity CohortRecruiting · University of California, San Francisco · San Francisco, California